Acamprosate DR
Class
Alcohol deterrents
Subclass
GABA and NMDA receptor modulators
Generic name
Acamprosate calcium, calcium acetylhomotaurinate, N-acetylhomotaurine DR
Brand names
Campral®
Common formulations
Tablet
Dosage and administration
Adults patients
Treatment of alcohol use disorder • Maintenance of abstinence
Indications for use
Labeled indications
Adults
Safety risks
Contraindications
Hypersensitivity to acamprosate or its components
Warnings and precautions
Alcohol withdrawal syndrome
Somnolence
Suicidal ideation, depression
Specific populations
Renal impairment
CrCl ≥ 50 mL/min
CrCl 30-50 mL/min
CrCl ≤ 30 mL/min
Renal replacement therapy
Any modality
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: B2
Breastfeeding
Use only if benefits outweigh potential risks.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource